A multi-state cross-sectional analysis across 13 states and 98 counties has found that chronic kidney disease (CKD) remains ...

A multi-omics study identifies causal genes and biological subtypes of long COVID, revealing new therapeutic targets for ...

A systematic review and meta-analysis finds that the definition of severe acute respiratory infection (SARI) used by the ...

As COVID completes its sixth year, official statistics obscure the scale of harm, while Long COVID and excess deaths reveal ...

Learn more about whether Twist Bioscience Corporation or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Long COVID—defined as symptoms persisting ≥ 2 months beyond acute SARS-CoV-2 infection without alternative explanation—now ...

NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) said interim results from a mid-stage clinical trial suggest its experimental COVID-19 treatment ratutrelvir may offer a differentiated alternative to ...

KAIST team uses AI-driven protein design and advanced intranasal delivery to stabilise interferon-lambda to achieve a ...

The 2024-2025 COVID-19 vaccines offered protection against COVID-19-associated ED and urgent care visits among pediatric populations in the US.

The authors of a new Australian study say they have identified a set of 32 genetic variants that increase the likelihood of ...

This study merges causal genetics and network theory, revealing 32 genes linked to long COVID, offering insights for ...

The global antibody drug conjugates market size was US$ 4,990.8 million in 2021. The global antibody drug conjugates s market size is forecast to reach US$ 33,150.3 million by 2030, growing at a CAGR ...